In CardioNet, LLC, et al. v. InfoBionic, Inc., the Federal Circuit reversed a district court’s ruling that affirmed a defendant’s 12(b)(6) motion that the asserted claims are invalid under 35 U.S.C. § 101, based on step one...more
5/14/2020
/ Appeals ,
CLS Bank v Alice Corp ,
Extrinsic Evidence ,
Failure To State A Claim ,
Federal Rule 12(b)(6) ,
Motion to Dismiss ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Reversal ,
Section 101 ,
Written Descriptions
The Federal Circuit recently affirmed a district court’s determination, holding a group of patents invalid for indefiniteness.
In December 2014, HZNP Medicines LLC (“Horizon”) brought suit against Actavis Laboratories UT,...more
11/11/2019
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Generic Drugs ,
Indefiniteness ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Summary Judgment